The Highest Quality CBD Oil

Meticulously sourced.
Thoughtfully produced.
100% organic.
Discover the difference.
August 14, 2018 | by Healthcare Weekly Staff

How Will Healthcare Pick Itself Up After a Dip in the Stock Market?

How FDA-Approved Devices Help Patients with Rare Diseases

Jo Natauri is the Global Head of Healthcare Investing in Goldman Sachs’ Merchant Banking Division. “Operating-wise, these businesses are performing really well,” Natauri says. “Healthcare is a defensive industry. But if you look at the environment right now, it’s really tied to the risk around policy.”

From consumers’ growing influence and vertical consolidation to the shift to value-based care and questions around drug pricing policy, there’s a lot going on in the healthcare industry. The healthcare industry is currently experiencing business model shifts, technological breakthroughs, and changes in policy under new government orders. Healthcare has been volatile in the stock market, and this videos aims to address how to combat some of these negative changes.

Looking from an operating standpoint, healthcare entities are still performing well, margins and growth profile are the highest they have been in recent history. People think the downdraft are macro issues: inflation, interest rate, and tax reform. Investors are fatigued with value creating activity, and so this talk aims to identify how healthcare is going about securing money from investors and bolstering their numbers in the stock market and beyond.

Accenture Presents Healthtech Innovation Challenge
Healthcare Weekly Staff
Healthcare Weekly Staff

The Healthcare Weekly staff brings you the latest in healthcare innovation, technology, news and more.
Healthcare Innovation Summit 2017 - Robert Pearl

Contact us

Get in touch to learn how we can help


Work Email


Thank you for contacting Healthcare Weekly.

We will get in touch with you shortly.